Edition:
India

Acorda Therapeutics Inc (ACOR.OQ)

ACOR.OQ on NASDAQ Stock Exchange Global Select Market

1.73USD
2:29am IST
Change (% chg)

$0.21 (+13.82%)
Prev Close
$1.52
Open
$1.55
Day's High
$1.75
Day's Low
$1.50
Volume
368,882
Avg. Vol
468,189
52-wk High
$21.08
52-wk Low
$1.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.99 December 22 Nov 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 1 1
(3) HOLD 4 6 6 6
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-19 7 37.68 43.80 27.26 46.98
Quarter Ending Mar-20 6 33.96 44.30 16.56 --
Year Ending Dec-19 7 179.29 185.70 169.17 146.65
Year Ending Dec-20 7 146.32 212.00 64.22 229.02
Earnings (per share)
Quarter Ending Dec-19 7 -0.99 -0.33 -2.96 -0.84
Quarter Ending Mar-20 6 -0.61 -0.30 -1.00 --
Year Ending Dec-19 7 -7.37 -2.92 -10.09 -3.88
Year Ending Dec-20 7 -1.99 -0.64 -3.63 -2.50

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-19 44.73 47.72 3.00 6.70
Quarter Ending Jun-19 28.82 50.05 21.24 73.70
Quarter Ending Mar-19 33.04 44.14 11.09 33.57
Quarter Ending Dec-18 48.12 69.15 21.04 43.72
Quarter Ending Sep-18 82.81 142.81 60.00 72.46

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-19 37.68 37.68 39.78 40.56 46.98
Quarter Ending Mar-20 33.96 33.96 31.71 31.70 --
Year Ending Dec-19 179.29 179.29 179.00 180.22 146.65
Year Ending Dec-20 146.32 146.32 155.15 158.62 229.02

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-19 0 0 3 4
Quarter Ending Mar-20 0 0 2 1
Year Ending Dec-19 0 0 3 4
Year Ending Dec-20 0 0 2 4
Earnings